Skip to main content

Table 4 Mean baseline and post-dose shifts in FEV1 for each treatment arm

From: The effect of glycopyrronium and indacaterol, as monotherapy and in combination, on the methacholine dose-response curve of mild asthmatics: a randomized three-way crossover study

Treatment:

Baseline FEV1 (L)

FEV1 1 h (L)

FEV1 24 h (L)

FEV1 48 h (L)

LAMA

3.25

[2.77-3.73]

3.31

[2.86-3.76]

3.33

[2.87-3.79]

3.26

[2.82-3.71]

uLABA

3.32

[2.91-3.72]

3.31

[2.91-3.72]

3.34

[2.94-3.73]

3.29

[2.89-3.69]

Combo

3.16

[2.70-3.62]

3.25

[2.77-3.72]

3.26

[2.78-3.74]

3.32

[2.83-3.81]

  1. [], 95% confidence intervals; FEV 1 , forced expiratory volume in 1 s, LAMA long-acting muscarinic antagonist, uLABA ultra-long acting β2 agonist, Combo combination therapy
Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us